Nurr1 expression is modified by inflammation in microglia.

Area of Science:

• Neuroscience
• Developmental Biology
• Immunology

Background:

• Neonatal care advances improve premature infant survival but neurological deficits persist.
• Maternal inflammation and neonatal hyperoxia are key risk factors for adverse neurodevelopmental outcomes.
• Nurr1 (NR4A2), a nuclear receptor, is crucial for dopamine neuron development and may regulate neuroinflammation.

Purpose of the Study:

• To investigate the hypothesis that combined maternal inflammation and neonatal hyperoxia increase Nurr1 expression in microglia.
• To examine Nurr1 expression in a mouse model and an immortalized microglia cell line (BV2 cells).

Main Methods:

• Mice were exposed to lipopolysaccharide (LPS) and hyperoxia during the perinatal period.
• Whole-brain homogenates and isolated primary microglia were analyzed for Nurr1 protein and message.
• BV2 cells were treated with hyperoxia and/or LPS to assess Nurr1 expression.

Main Results:

• Nurr1 protein expression increased in whole-brain homogenates at postnatal days 0 and 28 in exposed mice.
• Nurr1 message decreased in isolated microglia at postnatal day 60.
• In BV2 cells, hyperoxia increased Nurr1 message, but LPS co-exposure attenuated this effect.

Conclusions:

• Nurr1 expression is complex and differentially regulated by inflammation and hyperoxia in different cell types.
• Nurr1 plays a significant role in brain inflammation.
• Understanding Nurr1 regulation may offer novel therapeutic strategies for neurodevelopmental disorders.